Gregory S Day, MD MSc FRCPC
2006, Masters of Science (Physiology/Neuroscience): Queen’s University, Kingston, Ontario, Canada
2009, Medical Doctorate: Queen’s University, Kingston, Ontario, Canada
2014, Postgraduate Medical Education (Residency), Adult Neurology: University of Toronto, Toronto, Ontario, Canada
2015, Postdoctoral Fellowship (Memory and Aging): Washington University in St. Louis, St. Louis, MO
Fellow of the Royal College of Physicians and Surgeons of Canada (board certification in Neurology)
John Wherrett Award for Outstanding Neurology Resident Research, University of Toronto (2013)
Future Leader in Dementia Award, Pfizer Canada (2013)
André Barbeau Memorial Prize for Basic Science Research, Canadian Neurological Society (2014)
J.T. Marotta Teaching Award, University of Toronto, Department of Medicine (2014)
Eugene M Johnson, Jr. Weston Brain Institute Postdoctoral Fellowship, Weston Brain Institute (2015)
Distinguished Reviewer of the Year, Canadian Journal of Neurological Sciences (2015)
American Brain Foundation, Clinical Research Training Fellowship (2016)
I maintain special clinical interest in the diagnosis and management of patients with rapidly progressive dementia (including Creutzfeldt-Jakob disease), and autoimmune-mediated encephalitis (including patients with NMDA-receptor encephalitis and similar diseases).
My research strives to integrate clinical (e.g., symptoms and signs) and paraclinical measures (e.g., structural/functional/PET neuroimaging, cerebrospinal fluid biomarkers) to inform the pathophysiology of neurodegenerative and autoimmune causes of dementia, while improving diagnostic accuracy, access to disease-modifying therapies, and patient outcomes.